155 related articles for article (PubMed ID: 15031203)
1. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Oosten LE; Blokland E; van Halteren AG; Curtsinger J; Mescher MF; Falkenburg JH; Mutis T; Goulmy E
Blood; 2004 Jul; 104(1):224-6. PubMed ID: 15031203
[TBL] [Abstract][Full Text] [Related]
2. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
[TBL] [Abstract][Full Text] [Related]
3. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
[TBL] [Abstract][Full Text] [Related]
4. General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.
den Haan JM; Mutis T; Blokland E; IJzerman AP; Goulmy E
Blood; 2002 Feb; 99(3):985-92. PubMed ID: 11807003
[TBL] [Abstract][Full Text] [Related]
5. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Schilbach K; Kerst G; Walter S; Eyrich M; Wernet D; Handgretinger R; Xie W; Rammensee HG; Müller I; Bühring HJ; Niethammer D
Blood; 2005 Jul; 106(1):144-9. PubMed ID: 15731181
[TBL] [Abstract][Full Text] [Related]
8. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
[TBL] [Abstract][Full Text] [Related]
9. Peptide length extension skews the minor HA-1 antigen presentation toward activated dendritic cells but reduces its presentation efficiency.
Hambach L; Aghai Z; Pool J; Kröger N; Goulmy E
J Immunol; 2010 Oct; 185(8):4582-9. PubMed ID: 20855877
[TBL] [Abstract][Full Text] [Related]
10. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
Kloosterboer FM; van Luxemburg-Heijs SA; van Soest RA; Barbui AM; van Egmond HM; Strijbosch MP; Kester MG; Marijt WA; Goulmy E; Willemze R; Falkenburg JH
Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
[TBL] [Abstract][Full Text] [Related]
12. Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells.
Eljaafari A; Farre A; Duperrier K; Even J; Vie H; Michallet M; Souillet G; Catherine Freidel A; Gebuhrer L; Rigal D
Transplantation; 2001 May; 71(10):1449-55. PubMed ID: 11391234
[TBL] [Abstract][Full Text] [Related]
13. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
[TBL] [Abstract][Full Text] [Related]
14. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
15. Induction of tumor antigen-specific cytotoxic T cell responses in naïve mice by latex microspheres-based artificial antigen-presenting cell constructs.
Shen C; Zhang J; Xia L; Meng F; Xie W
Cell Immunol; 2007 May; 247(1):28-35. PubMed ID: 17720150
[TBL] [Abstract][Full Text] [Related]
16. Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
Meyer zum Büschenfelde C; Nicklisch N; Rose-John S; Peschel C; Bernhard H
J Immunol; 2000 Oct; 165(7):4133-40. PubMed ID: 11034426
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
[TBL] [Abstract][Full Text] [Related]
18. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
19. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
Eiz-Vesper B; Horn PA; Daubert C; Khattab B; Blasczyk R
Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
[TBL] [Abstract][Full Text] [Related]
20. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Oostvogels R; Minnema MC; van Elk M; Spaapen RM; te Raa GD; Giovannone B; Buijs A; van Baarle D; Kater AP; Griffioen M; Spierings E; Lokhorst HM; Mutis T
Leukemia; 2013 Mar; 27(3):642-9. PubMed ID: 23079962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
